Champions Oncology, Inc. CSBR
4.90
(0.05)
(1.01%)
as of 25 Sep
- Market cap
- $68.9M
- P/E
- 0.0×
Follow CSBR
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Older periods | |
|---|---|---|---|---|---|
| (28.38%) | (29.97%) | (46.96%) | 100.24% |
+8 more TTM periods Free account |
|
| (3.56%) | (3.96%) | (7.83%) | 8.89% | ||
ROIC |
(626.23%) | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(26.09%) | (41.62%) | (71.96%) | 78.36% | |
Average Days of Receivables |
81.84 | 80.94 | 76.01 | 72.09 | |
Free Cash Flow per Share |
(0.44) | (0.36) | 0.28 | 0.41 | |
Free Cash Flow |
(6.11) | (5.01) | 3.84 | 5.64 | |
Capital Expenditures |
(0.55) | (0.54) | (0.55) | (0.58) | |
Piotroski F-Score |
2.00 | 2.00 | 2.00 | 7.00 | |
| Other line items | |||||
Cash ROIC |
(63.10%) | (50.02%) | 38.19% | 48.82% | |
Accounts Receivable Turnover |
5.26 | 4.87 | 4.16 | 5.31 | |
Accounts Payable Turnover |
5.81 | 5.54 | 5.80 | 5.37 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
67.53 | 81.54 | 66.64 | 75.05 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.27 | 0.26 | (0.02) | 0.03 | |
Research and Development Expense of Revenue |
15.41% | 15.29% | 15.41% | 14.34% | |
Selling, General and Administrative Expense of Revenue |
35.95% | 34.45% | 34.30% | 31.55% | |
Share Based Compensation of Revenue |
2.96% | 2.08% | 1.74% | 1.44% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
4.90 | 3.81 | (1.90) | 2.53 | |
Depreciation/Fixed assets |
0.35 | 0.39 | 0.39 | 0.38 | |
Capex/Depreciation |
(0.41) | (0.39) | (0.38) | (0.39) | |
Revenue per Share |
4.36 | 4.30 | 4.17 | 4.24 | |
Operating CF per Share |
(0.40) | (0.32) | 0.32 | 0.45 | |
Capex per Share |
(0.04) | (0.04) | (0.04) | (0.04) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
(1.87%) | (1.98%) | (3.99%) | 4.21% |
Columns are period end dates